Akoya Biosciences, Inc.
AKYA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$55,365 | -$63,323 | -$70,641 | -$42,935 |
| Dep. & Amort. | $7,654 | $8,890 | $7,149 | $4,792 |
| Deferred Tax | $4 | -$51 | $35 | -$155 |
| Stock-Based Comp. | $9,306 | $10,437 | $7,430 | $4,039 |
| Change in WC | -$13,885 | -$14,478 | $2,164 | -$4,561 |
| Other Non-Cash | $8,183 | $7,626 | $367 | $2,752 |
| Operating Cash Flow | -$44,103 | -$50,899 | -$53,496 | -$36,068 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2,456 | -$3,653 | -$7,360 | -$5,094 |
| Net Acquisitions | $0 | $0 | $55 | $0 |
| Inv. Purchases | -$104,293 | $0 | -$40,774 | $0 |
| Inv. Sales/Matur. | $82,698 | $7,000 | $34,000 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$24,051 | $3,347 | -$14,079 | -$5,094 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1,022 | $10,574 | $30,629 | -$322 |
| Stock Issued | $91 | $47,967 | $447 | $138,553 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | -$1,435 |
| Other Fin. Act. | -$2,274 | -$1,697 | -$2,350 | $239 |
| Financing Cash Flow | -$3,205 | $56,844 | $28,726 | $137,035 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$71,359 | $9,292 | -$38,849 | $95,873 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $83,824 | $74,532 | $113,381 | $17,508 |
| End Cash | $12,465 | $83,824 | $74,532 | $113,381 |
| Free Cash Flow | -$46,559 | -$54,552 | -$60,856 | -$41,162 |